NIH sends BioNTech ‘notice of default’ over Covid vaccine royalties

BioNTech disclosed on Monday that it received a “notice of default” from the NIH over alleged breaches to a license agreement related to its Pfizer-partnered Covid-19 vaccine.

The NIH says BioNTech owes royalties and “other related amounts” on Comirnaty sales, according to a securities filing. BioNTech revealed last week that it’s in a similar dispute with the University of Pennsylvania, though the school did not respond to a request for comment on Monday.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

African nations must take ownership of HIV response to reduce disease burden

Africa must take ownership of its HIV response, write Izukanji Sikazwe and Magda Robalo, co-chairs of the African-led HIV Control Working Group.

October 9, 2024

Ionis inches toward first solo drug launch with late-stage trial success for rare genetic disease therapy

Ionis Pharmaceuticals, a California biotech that has spearheaded the development of RNA-targeting medicines, announced on Tuesday that its drug against familial chylomicronemia syndrome, a rare

September 26, 2023

Smiths Medical recalls syringe pumps for software malfunction

Dive Brief: The Food and Drug Administration has categorized Smiths Medical’s correction of more than 50,000 syringe pumps in the U.S. as a Class I

February 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.